Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SNRS- Sunrise Technologies -- Ignore unavailable to you. Want to Upgrade?

To: David Jones who wrote (1902)	12/17/1998 9:51:00 AM
From: Sylvester	Read Replies (2) \| Respond to of 4140

Interesting, I finally have some news from our optho friends in LA. they evidently did well on the private placement. Nothing specific but they told me to expect volume to gradually drop and the stock to stay about level, or it could go down on small sells as shorters make on last play. Depends on where the gap is. Charts they tell me say about $5.75 although down pressure is having a hard time sustaining itself. If volume shrinks and we stay above $6.25, they say we'll suddenly see much higher block purchases, right after the first of the year, from optho groups, evidently committed to more than a million shares early next year. Also, they told me of fund managers who have interviewed opthos for their opinion about all available procedures. The majority are in favor of LTK. The most optomistic opinion is that SNRS is almost certainly to be the biotech of the year in 1999. The private placement was popular with money managers who knocked Sunrise as not having enough capital to market effectively. Now they have capital and some positive publicity plus a proven fast track team working with the FDA should produce a larger 1st quarter then anyone expects. We're in the quiet before the storm stage, and many investors with contrary agendas want to keep it there. But the storm is coming, and sooner then many are predicting. Boy I wish I had more money. Sylvester. PS My feeling is that the info in this post is generally known by many opthomologists. I understand your reasons for keeping quiet up to now, but it would be nice if someone could confirm or add to this.